Weight loss, another key therapeutic benefit of Mounjaro, generally occurs gradually over several weeks
For those with inflammatory bowel disease, celiac disease, SIBO, gastric bypass history, or chronic GI symptoms that may impair oral nutrient absorption
The injectable GLP-1 analogues segment currently dominates the market due to their proven efficacy, widespread physician preference, and established regulatory approvals
Today, there are GLP-1 drugs made for diabetic patients (e.g., Ozempic and Mounjaro) and GLP-1s intended for weight loss patients (e.g., Wegovy and Zepbound)
No matter what, Evening Bryan cannot eat food because if given the chance, hell eat too much and ruin life for Sleep Bryan, Morning Bryan, Work Bryan and Dad Bryan